-
1
-
-
33846857559
-
Heart disease and stroke statistics - 2007 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
-
Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, et al. Heart disease and stroke statistics - 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007; 115:e69-e171.
-
Circulation
, vol.2007
, Issue.115
-
-
Rosamond, W.1
Flegal, K.2
Friday, G.3
Furie, K.4
Go, A.5
Greenlund, K.6
-
2
-
-
0033781454
-
Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology
-
Griendling KK, Sorescu D, Lassegue B, Ushio-Fukai M. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol 2000; 20:2175-2183. (Pubitemid 30777771)
-
(2000)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.20
, Issue.10
, pp. 2175-2183
-
-
Griendling, K.K.1
Sorescu, D.2
Lassegue, B.3
Ushio-Fukai, M.4
-
3
-
-
0037189377
-
Myeloperoxidase, a leukocyte-derived vascular NO oxidase
-
Eiserich JP, Baldus S, Brennan ML, Ma W, Zhang C, Tousson A, et al. Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science 2002; 296:2391-2394.
-
(2002)
Science
, vol.296
, pp. 2391-2394
-
-
Eiserich, J.P.1
Baldus, S.2
Brennan, M.L.3
Ma, W.4
Zhang, C.5
Tousson, A.6
-
4
-
-
0014941814
-
Myeloperoxidase: Contribution to the microbicidal activity of intact leukocytes
-
Klebanoff SJ. Myeloperoxidase: contribution to the microbicidal activity of intact leukocytes. Science 1970; 169:1095-1097.
-
(1970)
Science
, vol.169
, pp. 1095-1097
-
-
Klebanoff, S.J.1
-
5
-
-
34347225913
-
Serum Myeloperoxidase Levels Are Associated with the Future Risk of Coronary Artery Disease in Apparently Healthy Individuals. the EPIC-Norfolk Prospective Population Study
-
DOI 10.1016/j.jacc.2007.03.033, PII S0735109707013460
-
Meuwese MC, Stroes ES, Hazen SL, van Miert JN, Kuivenhoven JA, Schaub RG, et al. Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study. J Am Coll Cardiol 2007; 50:159-165. (Pubitemid 47002189)
-
(2007)
Journal of the American College of Cardiology
, vol.50
, Issue.2
, pp. 159-165
-
-
Meuwese, M.C.1
Stroes, E.S.G.2
Hazen, S.L.3
Van Miert, J.N.4
Kuivenhoven, J.A.5
Schaub, R.G.6
Wareham, N.J.7
Luben, R.8
Kastelein, J.J.P.9
Khaw, K.-T.10
Boekholdt, S.M.11
-
7
-
-
0035824162
-
Association between myeloperoxidase levels and risk of coronary artery disease
-
Zhang R, Brennan ML, Fu X, Aviles RJ, Pearce GL, Penn MS, et al. Association between myeloperoxidase levels and risk of coronary artery disease. JAMA 2001; 286:2136-2142. (Pubitemid 34041599)
-
(2001)
Journal of the American Medical Association
, vol.286
, Issue.17
, pp. 2136-2142
-
-
Zhang, R.1
Brennan, M.-L.2
Fu, X.3
Aviles, R.J.4
Pearce, G.L.5
Penn, M.S.6
Topol, E.J.7
Sprecher, D.L.8
Hazen, S.L.9
-
8
-
-
0028292033
-
Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions
-
Daugherty A, Dunn JL, Rateri DL, Heinecke JW. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest 1994; 94:437-444. (Pubitemid 24218123)
-
(1994)
Journal of Clinical Investigation
, vol.94
, Issue.1
, pp. 437-444
-
-
Daugherty, A.1
Dunn, J.L.2
Rateri, D.L.3
Heinecke, J.W.4
-
9
-
-
0034534961
-
Nitric oxide is a physiological substrate for mammalian peroxidases
-
DOI 10.1074/jbc.275.48.37524
-
Abu-Soud HM, Hazen SL. Nitric oxide is a physiological substrate for mammalian peroxidases. J Biol Chem 2000; 275:37524-37532. (Pubitemid 32004861)
-
(2000)
Journal of Biological Chemistry
, vol.275
, Issue.48
, pp. 37524-37532
-
-
Abu-Soud, H.M.1
Hazen, S.L.2
-
10
-
-
0032701646
-
Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro
-
Podrez EA, Schmitt D, Hoff HF, Hazen SL. Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro. J Clin Invest 1999; 103:1547-1560.
-
(1999)
J Clin Invest
, vol.103
, pp. 1547-1560
-
-
Podrez, E.A.1
Schmitt, D.2
Hoff, H.F.3
Hazen, S.L.4
-
11
-
-
4444292600
-
The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport
-
DOI 10.1073/pnas.0405292101
-
Bergt C, Pennathur S, Fu X, Byun J, O'Brien K, McDonald TO, et al. The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport. Proc Natl Acad Sci U S A 2004; 101:13032-13037. (Pubitemid 39167578)
-
(2004)
Proceedings of the National Academy of Sciences of the United States of America
, vol.101
, Issue.35
, pp. 13032-13037
-
-
Bergt, C.1
Pennathur, S.2
Fu, X.3
Byun, J.4
O'Brien, K.5
McDonald, T.O.6
Singh, P.7
Anantharamaiah, G.M.8
Chait, A.9
Brunzell, J.10
Geary, R.L.11
Oram, J.F.12
Heinecke, J.W.13
-
12
-
-
0242329721
-
Neutrophil myeloperoxidase activity and the influence of two singlenucleotide promoter polymorphisms
-
Rutgers A, Heeringa P, Giesen JE, Theunissen RT, Jacobs H, Tervaert JW. Neutrophil myeloperoxidase activity and the influence of two singlenucleotide promoter polymorphisms. Br J Haematol 2003; 123:536-538.
-
(2003)
Br J Haematol
, vol.123
, pp. 536-538
-
-
Rutgers, A.1
Heeringa, P.2
Giesen, J.E.3
Theunissen, R.T.4
Jacobs, H.5
Tervaert, J.W.6
-
13
-
-
1542349774
-
Peroxisome proliferator-activated receptor gamma ligands regulate myeloperoxidase expression in macrophages by an estrogen-dependent mechanism involving the -463GA promoter polymorphism
-
Kumar AP, Piedrafita FJ, Reynolds WF. Peroxisome proliferator-activated receptor gamma ligands regulate myeloperoxidase expression in macrophages by an estrogen-dependent mechanism involving the -463GA promoter polymorphism. J Biol Chem 2004; 279:8300-8315.
-
(2004)
J Biol Chem
, vol.279
, pp. 8300-8315
-
-
Kumar, A.P.1
Piedrafita, F.J.2
Reynolds, W.F.3
-
14
-
-
0033004381
-
Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease
-
DOI 10.1006/exnr.1998.6977
-
Reynolds WF, Rhees J, Maciejewski D, Paladino T, Sieburg H, Maki RA, et al. Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease. Exp Neurol 1999; 155:31-41. (Pubitemid 29072602)
-
(1999)
Experimental Neurology
, vol.155
, Issue.1
, pp. 31-41
-
-
Reynolds, W.F.1
Rhees, J.2
Maciejewski, D.3
Paladino, T.4
Sieburg, H.5
Maki, R.A.6
Masliah, E.7
-
15
-
-
0030764896
-
Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis
-
DOI 10.1016/S0165-5728(97)00089-1, PII S0165572897000891
-
Nagra RM, Becher B, Tourtellotte WW, Antel JP, Gold D, Paladino T, et al. Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis. J Neuroimmunol 1997; 78:97-107. (Pubitemid 27394430)
-
(1997)
Journal of Neuroimmunology
, vol.78
, Issue.1-2
, pp. 97-107
-
-
Nagra, R.M.1
Becher, B.2
Tourtellotte, W.W.3
Antel, J.P.4
Gold, D.5
Paladino, T.6
Smith, R.A.7
Nelson, J.R.8
Reynolds, W.F.9
-
16
-
-
0042884465
-
Effect of long-term hormone replacement therapy on atherosclerosis progression in postmenopausal women relates to myeloperoxidase promoter polymorphism
-
DOI 10.1210/jc.2002-021771
-
Makela R, Dastidar P, Jokela H, Saarela M, Punnonen R, Lehtimaki T. Effect of long-term hormone replacement therapy on atherosclerosis progression in postmenopausal women relates to myeloperoxidase promoter polymorphism. J Clin Endocrinol Metab 2003; 88:3823-3828. (Pubitemid 37034534)
-
(2003)
Journal of Clinical Endocrinology and Metabolism
, vol.88
, Issue.8
, pp. 3823-3828
-
-
Makela, R.1
Dastidar, P.2
Jokela, H.3
Saarela, M.4
Punnonen, R.5
Lehtimaki, T.6
-
17
-
-
0032787687
-
Higher relative, but lower absolute risks of myocardial infarction in women than in men: Analysis of some major risk factors in the SHEEP study
-
DOI 10.1046/j.1365-2796.1999.00554.x
-
Reuterwall C, Hallqvist J, Ahlbom A, De Faire U, Diderichsen F, Hogstedt C, et al. Higher relative, but lower absolute risks of myocardial infarction in women than in men: analysis of some major risk factors in the SHEEP study. The SHEEP Study Group. J Intern Med 1999; 246:161-174. (Pubitemid 29378921)
-
(1999)
Journal of Internal Medicine
, vol.246
, Issue.2
, pp. 161-174
-
-
Reuterwall, C.1
Hallqvist, J.2
Ahlbom, A.3
De Faire, U.4
Diderichsen, F.5
Hogstedt, C.6
Pershagen, G.7
Theorell, T.8
Wiman, B.9
Wolk, A.10
-
18
-
-
0344464788
-
Interleukin-6 serum levels and genotypes influence the risk for myocardial infarction
-
DOI 10.1016/j.atherosclerosis.2003.08.029
-
Bennet AM, Prince JA, Fei GZ, Lyrenas L, Huang Y, Wiman B, et al. Interleukin-6 serum levels and genotypes influence the risk for myocardial infarction. Atherosclerosis 2003; 171:359-367. (Pubitemid 37486089)
-
(2003)
Atherosclerosis
, vol.171
, Issue.2
, pp. 359-367
-
-
Bennet, A.M.1
Prince, J.A.2
Fei, G.-Z.3
Lyrenas, L.4
Huang, Y.5
Wiman, B.6
Frostegard, J.7
De Faire, U.8
-
19
-
-
66149189315
-
Variants in the Coagulation Factor 2 Receptor (F2R) gene influence the risk of myocardial infarction in men through an interaction with IL6 serum levels
-
Gigante B, Vikström M, Strö mqvist Meuzelaar L, Chernogubova E, Silveira A, van't Hooft F, et al. Variants in the Coagulation Factor 2 Receptor (F2R) gene influence the risk of myocardial infarction in men through an interaction with IL6 serum levels. Thromb Haemost 2009; 101:943-953.
-
(2009)
Thromb Haemost
, vol.101
, pp. 943-953
-
-
Gigante, B.1
Vikström, M.2
Strömqvist Meuzelaar, L.3
Chernogubova, E.4
Silveira, A.5
Van't Hooft, F.6
-
20
-
-
34547792981
-
Primary risk factors influence risk of recurrent myocardial infarction/death from coronary heart disease: Results from the Stockholm Heart Epidemiology Program (SHEEP)
-
DOI 10.1097/HJR.0b013e328012e3cc, PII 0014983120070800000009
-
Leander K,Wiman B, Hallqvist J, Andersson T, Ahlbom A, de Faire U. Primary risk factors influence risk of recurrent myocardial infarction/death from coronary heart disease: results from the Stockholm Heart Epidemiology Program (SHEEP). Eur J Cardiovasc Prev Rehabil 2007; 14:532-537. (Pubitemid 47229735)
-
(2007)
European Journal of Cardiovascular Prevention and Rehabilitation
, vol.14
, Issue.4
, pp. 532-537
-
-
Leander, K.1
Wiman, B.2
Hallqvist, J.3
Andersson, T.4
Ahlbom, A.5
De Faire, U.6
-
21
-
-
0035147075
-
Robust and accurate single nucleotide polymorphism genotyping by dynamic allele-specific hybridization (DASH): Design criteria and assay validation
-
DOI 10.1101/gr.150201
-
Prince JA, Feuk L, Howell WM, Jobs M, Emahazion T, Blennow K, et al. Robust and accurate single nucleotide polymorphism genotyping by dynamic allele-specific hybridization (DASH): design criteria and assay validation. Genome Res 2001; 11:152-162. (Pubitemid 32117961)
-
(2001)
Genome Research
, vol.11
, Issue.1
, pp. 152-162
-
-
Prince, J.A.1
Feuk, L.2
Howell, W.M.3
Jobs, M.4
Emahazion, T.5
Blennow, K.6
Brookes, A.J.7
-
22
-
-
1642313766
-
A new algorithm for haplotype-based association analysis: The Stochastic-EM algorithm
-
DOI 10.1046/j.1529-8817.2003.00085.x
-
Tregouet DA, Escolano S, Tiret L, Mallet A, Golmard JL. A new algorithm for haplotype-based association analysis: the Stochastic-EM algorithm. Ann Hum Genet 2004; 68 (Pt 2):165-177. (Pubitemid 38379847)
-
(2004)
Annals of Human Genetics
, vol.68
, Issue.2
, pp. 165-177
-
-
Tregouet, D.-A.1
Escolano, S.2
Tiret, L.3
Mallet, A.4
Golmard, J.L.5
-
23
-
-
0032944590
-
Sex difference in myeloperoxidase activity of neutrophils [3]
-
DOI 10.1002/(SICI)1096-8652(199904)60:4<312::AID-AJH13>3.0.CO;2-K
-
Kabutomori O, Yanagihara T, Iwatani Y, Kawarazaki A, Kabutomori M. Sex difference in myeloperoxidase activity of neutrophils. Am J Hematol 1999; 60:312-313. (Pubitemid 29160095)
-
(1999)
American Journal of Hematology
, vol.60
, Issue.4
, pp. 312-313
-
-
Kabutomori, O.1
Yanagihara, T.2
Iwatani, Y.3
Kawarazaki, A.4
Kabutomori, M.5
-
24
-
-
0034974531
-
Induced myeloperoxidase activity and related superoxide inhibition during hormone replacement therapy
-
DOI 10.1016/S0306-5456(00)00108-X, PII S030654560000108X
-
Bekesi G, Kakucs R, Varbiro S, Feher J, Pazmany T, Magyar Z, et al. Induced myeloperoxidase activity and related superoxide inhibition during hormone replacement therapy. BJOG 2001; 108:474-481. (Pubitemid 32607311)
-
(2001)
British Journal of Obstetrics and Gynaecology
, vol.108
, Issue.5
, pp. 474-481
-
-
Bekesi, G.1
Kakucs, R.2
Varbiro, S.3
Feher, J.4
Pazmany, T.5
Magyar, Z.6
Sprintz, D.7
Szekacs, B.8
|